Showing results (331-340 of 431) with videos related to

Sort By:
Pageof 44
Tissue Antigens|March 1, 1983
Study of a family with Cerebrotendinous Xanthomatosis. No HLA linkage, but an informative recombination between HLA-B and BfC Brautbar, O Yehuda, S Eisenberg, et al.
Dermatology Online Journal|February 23, 2018
Familial pseudoxanthoma elasticum associated with multiple comedonesMelody Maarouf, Victoria R Sharon, Raja K Sivamani, et al.
Frontiers in Allergy|April 7, 2022
Virtual Reality Reduces Pediatric Anxiety During Food Allergy Clinical Trials: A Pilot Randomized, Pragmatic StudySarah Alonzi, Thomas J Caruso, Sayantani B Sindher, et al.
Journal of Medicinal Chemistry|May 23, 2026
Mitigating Excessive Mitochondrial Fission Through the Development of a Selective Macrocyclic Inhibitor Targeting Fis1/Mid51 SignalingMulate Zerihun, Sayan Chakraborty, Ayetenew Abita, et al.
American Journal of Obstetrics and Gynecology|May 20, 2000
Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety studyJ M Moutquin, D Sherman, H Cohen, et al.
Biochimie|July 1, 1991
The interplay between X-ray crystallography, neutron diffraction, image reconstruction, organo-metallic chemistry and biochemistry in structural studies of ribosomesM Eisenstein, R Sharon, Z Berkovitch-Yellin, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 16, 2001
Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemiaR Elhasid, N Lanir, R Sharon, et al.
Dermatology Online Journal|May 3, 2016
Mercury toxicity presenting as acrodynia and a papulovesicular eruption in a 5-year-old girlOlivia Lai, Kory K Parsi, Davina Wu, et al.
Tissue Antigens|September 1, 1980
HLA-DRw4 in pemphigus vulgaris patients in IsraelC Brautbar, M Moscovitz, T Livshits, et al.
Cancer|January 5, 2000
Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia: the Israel National Study reportB Stark, R Sharon, G Rechavi, et al.
Pageof 44